ElpasBio Holdings is a leading clinical-stage biotechnology company focused on regenerative medicine and brings proven experience and capabilities in developing world-class cell therapy products. ElpasBio has more than 15 years of expertise in the stem cell field and has developed and explored multiple stem cell products across autologous and allogeneic approaches and various cell sources. ElpasBio operates GMP-compliant manufacturing and R&D facilities in Wuxi and Shanghai, China. It’s core product, AlloJoin®, is the first stem cell drug in China approved to enter into Phase III clinical trial for the treatment of knee osteoarthritis.
| Employees | 1 (0 on RocketReach) |
| Founded | 2009 |
| Industry | Biotechnology Research |
Looking for a particular ElpasBio employee's phone or email?
ElpasBio Questions
G2Crowd Trusted
300K+
Plugin Users
